跳转至内容
Merck
CN
  • Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk.

Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk.

Cell reports (2020-10-08)
Junting Huang, Maria A Gandini, Lina Chen, Said M'Dahoma, Patrick L Stemkowski, Hyunjae Chung, Daniel A Muruve, Gerald W Zamponi
摘要

The innate immune system responds to infections that give rise to pain. How the innate immune system interacts with the sensory nervous system and contributes to pain is poorly understood. Here we report that hyperactivity of innate immunity primes and initiates pain states via the TLR2-interleukin-33 (IL-33) axis. Toll-like receptors (TLRs) are upregulated in the complete Freund's adjuvant (CFA) pain model, and knockout of TLR2 abolishes CFA-induced pain. Selective activation of TLR2/6 triggers acute pain via upregulation of IL-33 in the hindpaw, dorsal root ganglia (DRG), and spinal cord in an NLRP3-dependent manner. The IL-33 increase further initiates priming of nociceptive neurons and pain states. Finally, blocking IL-33 receptors at the spinal level mediates analgesia during acute and chronic inflammatory pain, underscoring an important function of IL-33 in pain signaling. Collectively, our data reveal a critical role of the TLR2-IL-33 axis in innate immune activation for pain initiation and maintenance.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
前列腺素E2, ≥93% (HPLC), synthetic
Sigma-Aldrich
单克隆抗-神经丝蛋白 200 小鼠抗, clone NE14, ascites fluid